TERT and acute myeloid leukemia: In this context, DNA methylation is one of several epigenetic changes that impact the accessibility of the TERT promoter to the transcriptional machinery, thereby affecting TERT expression in AML [48,49], For example, DNA Methyltransferase Inhibitors can increase the effectiveness of imetelstat, a telomerase inhibitor in high-risk AML patients [50].